Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.77
-1.2200-4.52%
Pre-market: 23.11-2.6600-10.32%04:11 EDT
Volume:831.91K
Turnover:21.15M
Market Cap:1.52B
PE:-20.08
High:26.25
Open:26.22
Low:24.30
Close:26.99
Loading ...
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]